Screener
Kiniksa Pharmaceuticals International, plc KNSA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $175,677 | $165,596 |
| Short-term investments | 350,251 | 248,478 |
| Accounts receivable, net | 23,490 | 15,594 |
| Inventory | 70,930 | 54,895 |
| Prepaid expenses and other current assets | 48,285 | 42,614 |
| Total current assets | 668,633 | 527,177 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kiniksa Pharmaceuticals International, plc's short-term investments?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported short-term investments of $350.25M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's short-term investments changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's short-term investments increased by 202.6% year-over-year, from $115.75M to $350.25M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's short-term investments?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's short-term investments has grown at a 3.5% compound annual growth rate (CAGR), from $209.44M to $248.48M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Kiniksa Pharmaceuticals International, plc's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude